KOD - Kodiak Sciences Inc.
4.19
0.200 4.773%
Share volume: 401,972
Last Updated: 04-24-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$3.99
0.20
0.05%
View ratios
| Fiscal Date | 12-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q4 2024 | |
| Report Date | 03-27-2025 | |
| Assets | ||
| Total Assets | 335.578 M | |
| Current Assets | 171.936 M | |
| Inventories | 0.000 | |
| Other Current Assets | 0.000 | |
| Short Term Investments | 0.000 | |
| Total Receivables | 0.000 | |
| Current Cash | 168.074 M | |
| Total Non-current Assets | 0.000 | |
| Property Plant Equipment | 102.222 M | |
| Other Assets | 61.420 M | |
| Intangible Assets | 0.000 | |
| Goodwill | 0.000 | |
| Liabilities and shareholders’ equity | ||
| Total Liabilities and shareholders’ equity | 335.578 M | |
| Total liabilities | 185.290 M | |
| Total current liabilities | 25.573 M | |
| Accounts Payable | 3.915 M | |
| Other liabilities | 159.717 M | |
| Current long term debt | 0.000 | |
| Long term debt | 0.000 | |
| Other liabilities | 159.717 M | |
| Minority interest | 0.000 | |
| Total Shareholder equity | 150.288 M | |
| Common stock | 1.479 B | |
| Retained earnings | -1.329 B |
